Spinal fluid study for glioblastoma patients
Part of Cancer clinical trials.
This study looks at proteins in the spinal fluid, blood, and tumor tissue of people with glioblastoma. The goal is to learn more about the disease and find new ways to help patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with glioblastoma, confirmed by a biopsy or molecular testing.
- You are 18 years or older.
- You agree to take part in the study and can be followed up at the hospital in Guadalajara.
- You have a sample of your spinal fluid, blood, and tumor available.
- You are willing to let the researchers look at your medical records.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks people with glioblastoma (a type of aggressive brain tumor) over time to understand what affects their health and quality of life. If you take part, you'll fill out online surveys to help researchers learn how to improve care.
This study looks at how the brain's protective barrier works in people with glioblastoma. Researchers will study tumor tissue and use special scans to learn more, which might help improve future treatments.
This study aims to improve understanding of glioblastoma (and gliosarcoma) by preserving live, usable brain-tissue samples during brain surgery. If you’re having repeat tumor surgery or your scans suggest these cancers, the study may ask to collect tissue for research.
This study is for adults with glioblastoma, a type of brain cancer. It is an observational study that will follow participants to learn more about the disease.
This study uses a special MRI technique called magnetic resonance spectroscopy to look at chemical changes in glioblastoma tumors. It aims to find patterns that might help predict how the disease will progress, and it is meant for adults who have been recently diagnosed but have not yet started radiation or chemotherapy.
This trial uses special MRI scans and a contrast agent to look at the immune environment of glioblastoma tumors. It may help doctors learn more about how the tumor responds to treatment.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.